CIK: 0001703031 · Show all filings
Period: Q4 2017 (Next →)
Filing Date: Feb 14, 2018
Total Value ($000): $152,407 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | DICERNA PHARMACEUTICALS INC | 8,930,237 | $80,640 | 52.9% | $9.03 | — | COM | 253031108 |
| IFRX | INFLARX NV | 1,876,413 | $39,311 | 25.8% | $17.97 | 0.0% | COM | N44821101 |
| — | MARINUS PHARMACEUTICALS INC | 3,977,453 | $32,456 | 21.3% | $8.16 | — | COM | 56854Q101 |